ADHD trials recruiting in Arkansas

All ADHD trials nationally

Cities in Arkansas

Recruiting trials in Arkansas

• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
  NCT04781140 · Phase: Phase 4 · Ages: 48 Months to 69 Months · Sex: All (male and female) · Arkansas: Little Rock
• Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
  NCT07717879 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · Arkansas: Little Rock
• Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
  NCT07717892 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Arkansas: Little Rock
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Arkansas: Little Rock
• The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
  NCT06115603 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Arkansas: Fayetteville